HPIL Holding Stock Analysis:

Stock Target Advisor’s own stock analysis of HPIL Holding is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, HPIL Holding’s stock price was USD 0.0001. HPIL Holding’s stock price has changed by -80.00% over the past week, -90.91% over the past month and -98.70% over the last year.

What we like:

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

What we don’t like:

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Analysts rate Bed Bath & Beyond Inc with an Underperform rating and a 12-month average target price of $9.13 per share.

Yesterday Morgan Stanley maintained Bed Bath & Beyond Inc with an Underperform rating and slashed the target price to $2 from $7 on the company’s stock.

B. Riley lowered the target price on Bed Bath & Beyond Inc to $5 from $7 while maintaining the Neutral rating.

Based on the Bed Bath & Beyond Inc stock forecasts from 12 analysts, the average analyst target price for Bed Bath & Beyond Inc is USD 9.13 over the next 12 months. Bed Bath & Beyond Inc’s average analyst rating is Under-perform. Stock Target Advisor’s own stock analysis of Bed Bath & Beyond Inc is Bearish, which is based on 2 positive signals and 12 negative signals. At the last closing, Bed Bath & Beyond Inc’s stock price was USD 4.97. Bed Bath & Beyond Inc’s stock price has changed by -30.29% over the past week, -46.15% over the past month and -85.07% over the last year.

This week, as the stock plummets in the wake of a dismal quarter of profits and the resignation of the CEO, analysts are pessimistic about the future of Bed Bath & Beyond.

As of 11:25 a.m. ET, shares have decreased by 23 percent over the last two days from Tuesday’s close of $6.53 to $5.01.  The retailer’s latest decline follows a weak first quarter and the declaration that CEO Mark Tritton would step down from his post. Bed Bath & Beyond stated in an earnings release that the company struggled due to rising inflation, low customer confidence, and low demand for home items. The company recorded nearly $357 million in net losses for the first quarter.

What we like:

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What we don’t like:

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.

Analysts rate BioNTech SE with a consensus Buy rating and a 12-month average target price of $247.94 per share.

Yesterday Goldman Sachs maintained BioNTech SE with a Neutral rating and raised the target price to $209 from $206 on the company’s stock.

UBS maintained BioNTech SE with a Buy rating and lowered the target price to $168 from $300.

Based on the BioNTech SE stock forecasts from 10 analysts, the average analyst target price for BioNTech SE is USD 247.94 over the next 12 months. BioNTech SE’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of BioNTech SE is Bullish , which is based on 9 positive signals and 2 negative signals. At the last closing, BioNTech SE’s stock price was USD 149.10. BioNTech SE’s stock price has changed by +12.71% over the past week, -10.70% over the past month and -33.40% over the last year.

What we like:

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What we don’t like:

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Analysts rate Block Inc. with a consensus Strong Buy rating and a 12-month average target price of $172.43 per share.

Yesterday Truist Securities maintained Block Inc with a Buy rating and lowered the target price to $105 from $145 on the company’s stock.

Based on the Block Inc stock forecasts from 32 analysts, the average analyst target price for Block Inc is USD 172.43 over the next 12 months. Block Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Block Inc is Slightly Bullish , which is based on 7 positive signals and 5 negative signals. At the last closing, Block Inc’s stock price was USD 61.46. Block Inc’s stock price has changed by -8.64% over the past week, -32.10% over the past month and -74.79% over the last year.

What we like:

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What we don’t like:

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Analysts rate Walt Disney Company with a consensus Strong Buy rating and a 12-month average stock price of $161.62 per share.

Yesterday Morgan Stanley maintained the Overweight rating for Walt Disney Company and lowered the target price to $125 from $170 on the company’s stock.

Based on the Walt Disney Company stock forecasts from 23 analysts, the average analyst target price for Walt Disney Company is USD 161.62 over the next 12 months. Walt Disney Company’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Walt Disney Company is Bullish , which is based on 11 positive signals and 4 negative signals. At the last closing, Walt Disney Company’s stock price was USD 94.40. Walt Disney Company’s stock price has changed by +0.11% over the past week, -13.65% over the past month and -46.29% over the last year.

What we like:

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What we don’t like:

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.